课题基金 / 基金详情

The mechanism of the susceptibility to infection in diabetes and the new management

The mechanism of the susceptibility to infection in diabetes and the new management
糖尿病感染易感机制及新管理
批准号:
09671023
负责人:
SATO Noriyuki
金额:
$0.32万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

SATO Noriyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In poorly controlled diabetic patients and streptozotocin-induced diabetic rats, neutrophil bactericidal function (oxygen-derived free radicals generation) was clearly decreased. Especially, the generation of superoxide anion and the myeloperoxidase (MPO) dependent radicals were reduced compaired to control. The MPO activity was also decreased in neutrophils from poorly controlled diabetic patients, which was correlated to the increase in HbA1c.Two drugs, granulocyte-colony stimulating facto (G-CSF) and epairestat, an aldose reductase inhibitor, were improved the diabetic-induced decrease in the generation of oxygen-derived free radicals by poorly controlled diabetic patients and diabetic rats. This improvement by G-CSF was more significant in patients with more poorly blood glucose control. In diabetic rats, cytosolic sorbitol concentration was increased. Epalrestat not only suppressed this increase in sorbitol concentration but increased the impaired neutrophil bactericidal function. There was a negative correlation between epairestat-induced decrease in sorbitol concentration and epairestat-induced increase in neutrophil bactericidal function.It is well known that the susceptibility to infection is dependent on the impaired neutrophils bactericidal function. This study suggested that the susceptibility to infection in diabetes may be due to the impairment of the generation of oxygen-derived free radicals by neutrophils. Some drugs (e.g. (G-CSF and epairestat) may be useful as drug to prevent the susceptibility to infection in diabetes.
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
佐藤則之、 森 昌朋: "ミエロペルオキシダーゼ" 日本臨床. 56. 246-250 (1998)
Noriyuki Sato、Masatomo Mori:“髓过氧化物酶”日本临床杂志 56. 246-250 (1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sato,N., Kashima,K., Tanaka,Y., Shimizu,H., Mori,M.: "Effect of Granulocyte-colony stimulating factor on generation of oxygen-derived free radicals and myeloperoxidase activity in neutrophils from poorly controlled NIDDM patients" Diabetes. 46. 133-137 (1
Sato,N.、Kashima,K.、Tanaka,Y.、Shimizu,H.、Mori,M.:“粒细胞集落刺激因子对 NIDDM 控制不良的中性粒细胞中氧自由基生成和髓过氧化物酶活性的影响
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
佐藤 則之.清水 弘行.森 昌朋: "ミエロペルオキシダーゼ" 日本臨床(増刊号)糖尿病3. 728号. 246-250 (1998)
Noriyuki Sato。Hiroyuki Shimizu。Masayuki Mori:“髓过氧化物酶”日本临床(特刊)糖尿病 3. No. 728. 246-250 (1998)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
佐藤 則之, 森 昌朋: "甲状腺刺激ホルモン(TSH)" 臨床スポーツ医学(臨時増刊号)スポーツと臨床検査. 14巻. 115-117 (1997)
Noriyuki Sato,Masatomo Mori:“促甲状腺激素(TSH)”临床运动医学(特刊)运动和临床测试第 14 卷。115-117(1997 年)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
19
    Extracellular Hsp90 plays a pivotal role in innate immunity and adaptive immunity
    • 批准号:
      24659165
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2012
    • 负责人:
      SATO Noriyuki
    • 依托单位:
    A study on the economic structure of Mongolia in the Qing era from the viewpoint of the Chinese commercial district "Mai-mai-cheng"
    • 批准号:
      23720341
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.75万
    • 财政年份:
      2011
    • 负责人:
      SATO Noriyuki
    • 依托单位:
    patho-physiologic role of HSP90 in the aseptic inflammatory process
    • 批准号:
      22659075
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $1.98万
    • 财政年份:
      2010
    • 负责人:
      SATO Noriyuki
    • 依托单位:
    Molecular immunopathology of human cancer stem cell
    • 批准号:
      21249025
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $29.45万
    • 财政年份:
      2009
    • 负责人:
      SATO Noriyuki
    • 依托单位:
    海外基金